Ester Pungolino Selected Research

ruxolitinib

1/2022	Efficacy and safety of ruxolitinib in patients with myelofibrosis and low platelet count (50 × 109/L to <100 × 109/L) at baseline: the final analysis of EXPAND.
6/2017	Occult hepatitis B infection reactivation after ruxolitinib therapy.
8/2012	Long-term outcomes of 107 patients with myelofibrosis receiving JAK1/JAK2 inhibitor ruxolitinib: survival advantage in comparison to matched historical controls.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ester Pungolino Research Topics

Disease

13	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2023 - 12/2008
5	Neoplasms (Cancer) 01/2023 - 07/2002
3	Primary Myelofibrosis (Myelosclerosis) 01/2022 - 03/2010
2	Blast Crisis (Blast Phase) 11/2023 - 12/2008
1	Disease Progression 11/2023
1	Genetic Translocation (Chromosomal Translocation) 01/2023
1	Philadelphia Chromosome 01/2023
1	Anemia 01/2022
1	Thrombocytopenia (Thrombopenia) 01/2022
1	Edema (Dropsy) 09/2020
1	Fatigue 09/2020
1	Diarrhea 09/2020
1	Muscle Cramp (Cramp) 09/2020
1	Pleural Effusion (Pleural Effusions) 01/2018
1	Latent Infection 06/2017
1	Hepatitis B 06/2017
1	Splenomegaly 08/2012
1	Pathologic Complete Response 12/2008
1	Thrombotic Thrombocytopenic Purpura 10/2002
1	Infections 07/2002
1	Pneumonia (Pneumonitis) 07/2002
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 07/2002
1	Residual Neoplasm 07/2002
1	Monoclonal Gammopathy of Undetermined Significance 03/2002
1	Proteinuria 03/2002

Drug/Important Bio-Agent (IBA)

5	Imatinib Mesylate (Gleevec)FDA Link 11/2020 - 12/2008
4	nilotinib FDA Link 10/2021 - 12/2017
3	Tyrosine Kinase InhibitorsIBA 11/2023 - 12/2008
3	ruxolitinibIBA 01/2022 - 08/2012
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2023 - 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2023
1	bcr-abl Fusion ProteinsIBA 10/2021
1	venetoclaxIBA 03/2021
1	Oncogene Proteins (Oncogene Protein)IBA 01/2019
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2019
1	Dasatinib (BMS 354825)FDA Link 01/2018
1	amsonic acid (DAS)IBA 01/2018
1	Hemoglobins (Hemoglobin)IBA 03/2010
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2002
1	SteroidsIBA 10/2002
1	Acyclovir (Aciclovir)FDA LinkGeneric 07/2002
1	Alemtuzumab (Campath)FDA Link 07/2002
1	fludarabineIBA 07/2002
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 07/2002
1	Ganciclovir (Cytovene)FDA LinkGeneric 07/2002
1	Monoclonal AntibodiesIBA 07/2002
1	ParaproteinsIBA 03/2002
1	Immunoglobulins (Immunoglobulin)IBA 03/2002

Therapy/Procedure

4	Therapeutics 06/2017 - 10/2002
1	Aftercare (After-Treatment) 11/2023
1	Stem Cell Transplantation 12/2008
1	Plasma Exchange 10/2002